Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...
The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...
Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...
A new kind of COVID-19 vaccine is about to roll out around the world. It's called a protein subunit vaccine. Early on in the pandemic, many experts thought this was the kind of vaccine that would be ...
In a recent study posted to the bioRxiv pre-print* server, a team of researchers developed a broadly reactive and stable severe acute respiratory syndrome coronavirus 2 spike protein subunit 2 ...
PRINCETON, N.J., Sept. 4, 2025 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat ...
In a recent study published in Scientific Reports, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine. Study: An intranasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results